Colibri Heart Valve is developing disruptive, Ready-for-Use, structural heart technologies that address unmet patient and market needs.
The Colibri Transcatheter Aortic Valve Implantation (“TAVI”) System is expected to redefine transcatheter aortic heart valve implantation as it is the ONLY, true low profile Ready-for-Use TAVI system requiring no valve preparation prior to use.
Competing technologies are shipped to customers “wet” in a toxic glutaraldehyde preservation solutions and require cleaning, mounting, crimping, and loading at the point of use – the Colibri TAVI System does not.
Colibri’s products and technology are in clinical development. No devices or other products are currently offered for sale by the company. Discussion of the technical features of products under development do not in any way constitute claims for clinical effectiveness or pledges of future performance.